Table 3. Survival analysis with Cox Regression.
| Univariate Hazard ratio | 95% CI | p-value | Multi-variate Hazard ratio | 95% CI | p-value | |
|---|---|---|---|---|---|---|
| Sex (M/F) | 1.44/1.46 | 0.35~5.96/0.35~6.03 | 0.62/0.60 | 1.45/1.45 | 0.34~6.18/0.34~6.16 | 0.62/0.62 |
| Age | 1.00/1.01 | 0.97~1.04/0.98~1.05 | 0.79/0.46 | 0.99/1.01 | 0.96~1.03/0.97~1.04 | 0.74/0.78 |
| Stage | ||||||
| III&IV vs. I&II | 1.94/1.97 | 0.98~3.87/0.99~3.90 | 0.06/0.05 | 1.81/1.87 | 0.85~3.84/0.88~3.95 | 0.12/0.10 |
| Primary site | ||||||
| Oral | 1.00 | 1.00 | ||||
| OP | 1.27/1.19 | 0.57~2.82/0.54/2.63 | 0.56/0.66 | 1.12/1.01 | 0.49~2.55/0.45~2.27 | 0.79/0.99 |
| Hypo | 2.36/2.06 | 1.08~5.15/0.95~4.45 | 0.03/0.07 | 1.27/1.01 | 0.49~3.29/0.39~2.64 | 0.62/0.98 |
| Larynx | 1.21/1.14 | 0.44~3.35/0.41~3.12 | 0.71/0.81 | 1.10/0.99 | 0.39~3.12/0.35~2.78 | 0.86/0.98 |
| Other | 0.69/0.65 | 0.09~5.26/0.09~4.94 | 0.72/0.68 | 0.65/0.65 | 0.08~4.99/0.09~4.99 | 0.68/0.68 |
| PES | ||||||
| With SPT | 2.92/2.85 | 1.37~6.22/1.38~5.87 | <0.01/<0.01 | 2.75/2.79 | 1.11~6.82/1.15~6.80 | 0.03/0.02 |
Reported as esophageal neoplasia only/upper gastrointestinal tract neoplasia (including two gastric cancers).